Howard University is a private federally chartered historically black research university in Washington, D.C. It is classified among "R2: Doctoral Universities – High research activity" and accredited by the Middle States Commission on Higher Education.

During the past decade, Howard University conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 11 clinical trials were completed, i.e. on average, 57.9% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 5 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Howard University" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 19 trials, followed by "University of Southern California" with 5 trials sponsored, "Alzheimer's Disease Cooperative Study (ADCS)" with 4 trials sponsored, "Howard University" with 4 trials sponsored and "National Institute on Aging (NIA)" with 4 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Howard University" #1 collaborator was "National Institute on Aging (NIA)" with 11 trials as a collaborator, "Alzheimer's Therapeutic Research Institute" with 5 trials as a collaborator, "Howard University" with 5 trials as a collaborator, "Northern California Institute of Research and Education" with 5 trials as a collaborator and "National Institute on Drug Abuse (NIDA)" with 4 trials as a collaborator. Other collaborators include 55 different institutions and companies that were collaborators in the rest 53 trials.

According to Clinical.Site data, the most researched conditions in "Howard University" are "HIV Infections" (21 trials), "Alzheimer's Disease" (9 trials), "Sickle Cell Disease" (5 trials), "Alzheimer Disease" (4 trials) and "Depression" (3 trials). Many other conditions were trialed in "Howard University" in a lesser frequency.

Most popular intervention types in "Howard University" are "Drug" (41 trials), "Behavioral" (8 trials), "Other" (4 trials), "Procedure" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Zidovudine" (7 trials), "Indinavir sulfate" (6 trials), "Efavirenz" (5 trials) and "Nelfinavir mesylate" (5 trials). Other intervention names were less common.

The vast majority of trials in "Howard University" are 67 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Howard University". undefined are not yet recruiting, 8 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 50 completed trials in Howard University, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Howard University, 2 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 17 trials that are defined as “Not Applicable".